Accession Number:

AD1095209

Title:

Theranostics Targeting Metastatic Breast Cancer

Descriptive Note:

Technical Report,30 Sep 2017,29 Sep 2018

Corporate Author:

Texas A and M University College Station United States

Personal Author(s):

Report Date:

2018-10-01

Pagination or Media Count:

63.0

Abstract:

This application is designed to impact three of the overarching challenges identified for this award type i revolutionary treatment regimes replacing drugs that have life-threatening toxicities with safe and effective interventions ii elimination of mortality associated with metastatic breast cancer and, iii distinguishing aggressive breast cancer from indolent forms, to avoid over-diagnosis and treatment. Overall, this work addresses issues that relate to i revolutionary treatment regimes replacing drugs that have life-threatening toxicities with safe and effective interventions ii elimination of mortality associated with metastatic breast cancer and, iii distinguishing aggressive breast cancer from indolent forms, to avoid over-diagnosis and treatment.

Subject Categories:

  • Medicine and Medical Research
  • Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE